Assessing Risk of Adverse Pregnancy Outcomes for Immuno-Oncology Programs

The "Assessing Risk of Adverse Pregnancy Outcomes for Immuno-Oncology Programs" is 1 of 10 courses included in the Cancer Immunotherapies module. 

This course is led by Dr. Curtis Maier Director at Glaxo Smith Kline

Learning Objectives

  1. Understand the role of the immune system in successful pregnancy
  2. Appreciate that many of the pathways targeted in IO are also involved in maintaining pregnancy, particularly immune tolerance of fetal antigens
  3. Knowledge of regulatory guidance and different scientifically justified approaches for assessing reproductive toxicology risk with IO agents
Course summary
Course opens: 
03/22/2022
Course expires: 
03/23/2027
Cost:
$25.00
Rating: 
0

Price

Cost:
$25.00
Please login or register to take this course.